Types of failures for those with persistent disease on days 15 and 22-25 during remission induction
| . | Day 15 (n = 57)4-150 . | Day 22-25 (n = 27)4-150 . |
|---|---|---|
| Hematologic relapse | 16 | 12 |
| CNS relapse | 7 | 2 |
| Testicular relapse | 1 | 0 |
| Hematologic and CNS relapse | 2 | 1 |
| Second malignancy | 4 | 1 |
| Mediastinal relapse | 1 | 0 |
| . | Day 15 (n = 57)4-150 . | Day 22-25 (n = 27)4-150 . |
|---|---|---|
| Hematologic relapse | 16 | 12 |
| CNS relapse | 7 | 2 |
| Testicular relapse | 1 | 0 |
| Hematologic and CNS relapse | 2 | 1 |
| Second malignancy | 4 | 1 |
| Mediastinal relapse | 1 | 0 |
Total number of patients with persistent disease at these time points.